Virtus ETF Advisers LLC Vir Biotechnology, Inc. Transaction History
Virtus ETF Advisers LLC
- $234 Million
- Q4 2024
A detailed history of Virtus ETF Advisers LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 9,568 shares of VIR stock, worth $68,411. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,568
Previous 8,894
7.58%
Holding current value
$68,411
Previous $66,000
6.06%
% of portfolio
0.03%
Previous 0.03%
Shares
19 transactions
Others Institutions Holding VIR
# of Institutions
232Shares Held
90.1MCall Options Held
1.28MPut Options Held
235K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$119 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$118 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$93.9 Million0.0% of portfolio
-
State Street Corp Boston, MA5.07MShares$36.3 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$23 Million0.64% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $948M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...